Diabetes and metabolism

Lynnette Hoffman
Clinical Articles iconClinical Articles

Healthed survey finds that while many expect negative impact, they support changes...

Prof John Dixon
Videos iconVideos

In this Product Explainer, Bariatrician Prof John Dixon explains how the Allurion intragastric balloon works as part of a non-surgical weight loss strategy.

Dr Sarah Tedjasukmana
Clinical Articles iconClinical Articles

1 in 3 people with diabetic retinopathy are at high risk of vision loss, yet screening rates remain low…

Prof Richard O'Brien
Podcasts iconPodcasts

Prof Richard O'Brien, explains that diabetic retinopathy is a common but often very manageable complication of diabetes, provided it is detected early.

Prof Sunil Badve
Podcasts iconPodcasts

In this podcast, Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria.

A/Prof Samantha Hocking
Podcasts iconPodcasts

In this Healthed lecture, A/Prof Samantha Hocking provides an update on what this new treatment is.

Prof Sunil Badve
Videos iconVideos

In this Product Explainer, Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria.

Dr Duane Mellor
Clinical Articles iconClinical Articles

We have known about cases of type 2 diabetes going into remission, or glucose levels going back to normal, since the 1960s. But how likely is it that this treatment will work outside of the carefully controlled environment of a clinical trial?

Sophia Auld
Clinical Articles iconClinical Articles

Cases of diabetic ketoacidosis (DKA) in children are on the rise in Australia, sometimes with tragic consequences, says paediatric endocrinologist A/Prof Gary Leong—and empirical evidence supports this observation.

Expert/s: Sophia Auld
Dr Gary Deed
Podcasts iconPodcasts

The questions answered in this podcast are listed. They were compiled by GPs and health professionals around Australia regarding weight loss for better type 2 diabetes outcomes.

Expert/s: Dr Gary Deed
Manuela Callari
Clinical Articles iconClinical Articles

Ozempic has only been approved and funded for lowering blood glucose levels in people with T2D. Wegovy, the higher dose version of semaglutide, has been approved specifically for weight loss, learn more...

Healthed
Clinical Articles iconClinical Articles

Worldwide shortages cause to TGA put the brakes on prescribing

Expert/s: Healthed